An Assessment of the Effect of Food and Antacid on BIIB021 Pharmacokinetics in Subjects With Advanced Solid Tumors.

NCT01017198 Phase 1 COMPLETED

This study is designed to assess the effect of food and antacid use on the pharmacokinetic properties of BIIB021.

Details

Lead sponsor	Biogen
Phase	Phase 1
Status	COMPLETED
Enrolment	20
Start date	2009-11
Completion	2011-01

Conditions

• Advanced Solid Tumors

Interventions

• BIIB021 and Food
• BIIB0121 and Antacid

Primary outcomes

• The primary objective of the study is to assess the pharmacokinetics of BIIB021 taken under fed conditions compared to BIIB021 taken under fasting conditions in subjects with advanced solid tumors. — Cycle 1, Day 3

Countries

United States